Sebi Chairman Tuhin Kanta Pandey on Friday said the capital markets regulator is in the process of developing an artificial ...
The announcement follows two years of accelerated testing and regulatory navigation. Neuralink launched its first human trial in 2024, two years after the US Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback